Bringing the power of paperless execution to cell and gene therapy.
Cell and gene therapy is a rapidly changing area of pharmaceutical manufacturing experiencing significant innovation. Currently, process and sample data are captured manually using paper batch records, but these are slow, error-prone and can be difficult to track across the manufacturing lifecycle. To enable more efficient, effective and flexible data capture, Lonza has developed the innovative MODA-ES® Platform: a paperless batch record solution combining manufacturing and quality data designed to meet the needs of cell and gene therapy manufacturing.
Compared to traditional MES approaches the MODA-ES® Platform consolidates all cell and gene therapy manufacturing batch data, and batch-related quality control data, into a single record with an easy-to-use review and approval interface for expedited product release. With data integrity compliance and traceability at its core, the solution captures trends and key quality and performance metrics, while eliminating errors associated with paper-based approaches.
The MODA-ES® Platform is purpose-built by the end user, for the end user. This is reflected in the intuitive nature of the system, which enables quick and easy implementation, while innovative in-built features offer deep insight into operations and process, bringing valuable efficiency gains.
By focusing on flexibility, configurability and scalability the MODA-ES® Platform provides a range of options for expedited implementation and validation at an affordable price point and with a lower total cost of ownership. With a flexible, user-friendly workflow that is suitable for manufacturers of any size. The MODA-ES® Platform brings the power of MES to cell and gene therapy manufacturing.
Benefits for CGT organizations
- Built by the end user for the end user - a flexible, cost-effective MES solution to digitalize cell therapy manufacturing
- Combines quality and manufacturing in a single batch record
- Enable parallel processing with track and trace and maximize capacity to scale production
- Implementation team with experience in cell therapy manufacturing
- Easy configuration, implementation and validation
